A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment

NCT01509911 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: TL-118
DRUG: Gemcitabine

Sponsor

Tiltan Pharma Ltd.

Collaborators

[object Object]
[object Object]